Merck & Co., Inc.
MRK
$75.97
-$1.68-2.16%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 35.69% | 18.56% | -42.13% | 14.55% | 488.42% |
| Total Depreciation and Amortization | -5.03% | -2.79% | 7.50% | 16.00% | 1.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.26% | -81.38% | 1,779.69% | -83.82% | 86.12% |
| Change in Net Operating Assets | -100.11% | -171.84% | 355.14% | 70.08% | -2,448.61% |
| Cash from Operations | -27.54% | -62.87% | 64.82% | 82.43% | 1,156.10% |
| Capital Expenditure | -41.73% | -19.67% | 1.01% | 8.13% | 12.94% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 99.94% | -- | 100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.51% | -278.45% | 201.80% | -220.35% | -77.83% |
| Cash from Investing | -2.98% | 62.44% | -259.68% | 22.31% | -2,696.23% |
| Total Debt Issued | -- | 100.00% | -100.03% | -- | -- |
| Total Debt Repaid | -363.82% | -- | -- | 100.00% | -24,933.33% |
| Issuance of Common Stock | 58.33% | 140.00% | -93.15% | -16.09% | 1,350.00% |
| Repurchase of Common Stock | -138.04% | -10.14% | -76.89% | -105.74% | 68.96% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -5.07% | 0.10% | 1.66% | -1.85% | -5.29% |
| Other Financing Activities | -42.86% | -31.25% | 85.45% | -182.05% | -2,500.00% |
| Cash from Financing | -91.26% | -24.08% | -299.42% | 143.21% | -25.35% |
| Foreign Exchange rate Adjustments | 142.51% | -224.83% | 458.54% | 40.58% | -174.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -234.74% | -141.33% | -41.86% | 560.58% | 29.66% |